Validation of cerebrospinal fluid chitinase 3-like 1 as a prognostic biomarker of conversion to multiple sclerosis and disease severity in patients with clinically isolated syndromes. [AUT.] E. CANTÓ, M. TINTORÉ, C. COSTA, G. ARRAMBIDE, L. M. VILLAR, J. C. ÁLVARES-CERMEÑO, F. DEISENHAMMER, H. HEGEN, M. KHADEMI, T. OLSSON, F. PIEHL, A. BARTOS, D. SIMOVA, J. KOTOUCOVA, J. KUHLE, J. KAPPOS, J. A. GARCIA-MERINO, A. SAIZ, R. BLANKO, R. HINTZEN, N. JAFARI, D. BRASSAT, H. TUMANI, F. LAUDA, R. ROESLER, K[ONRAD] REJDAK, E[WA] PAPUĆ, C. DE ANDRÉS, M. KHALIL, D. GALIMBERTI, E. SCARPINI, X. MONTALBAN, M. COMABELLA. W: 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. 18th Annual Conference of Rehabilitation in MS. Copenhagen, 2-5 October 2013 [online] [b. pag.], [przeglądany 26 lutego 2014]. Dostępny w: http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=180281&XNSPRACHE_ID=2&XNKONGRESS_ID=195&XNMASKEN_ID=900.